Latest News about CVAC
Recent news which mentions CVAC
US Stocks Look Set To Carry Last Week's Momentum Forward On Monday — Focus Now On Inflation Data, Q4 Reporting Season
January 09, 2023
From Benzinga
From InvestorPlace
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 06, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Friday
December 23, 2022
From Benzinga
Researchers Working On Universal mRNA-Influenza Vaccine Aiming For Baseline Immune Memory For Diverse Strains
November 25, 2022
From Benzinga
Earnings Scheduled For November 16, 2022
November 16, 2022
From Benzinga
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
November 15, 2022
From Benzinga
Miniso Group, Monday.com And Other Big Gainers From Monday
November 15, 2022
From Benzinga
Dow Gains Over 50 Points; US Producer Prices Rise 0.4% In September
October 12, 2022
From Benzinga
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
September 23, 2022
From Benzinga
Apple, Amazon, HP And Other Big Losers From Friday
August 29, 2022
From Benzinga
From Benzinga
Moderna Entangles Pfizer/BioNTech In COVID-19 Vaccine Patent Lawsuits: All You Need To Know
August 26, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 25, 2022
From Benzinga
CureVac N.V. (CVAC) has initiated a Phase 1 clinical trial of a modified, Omicron-targeting COVID-19 vaccine candidate.
August 18, 2022
Tickers
CVAC
From Best Stocks
Fighting Omicron: This Covid Vaccine Candidate Is Going After The Dangerous Mutation
August 18, 2022
From Benzinga
From Benzinga
COVID hospitalizations dip for first time since mid-April, but daily deaths reach 2 1/2-month high
July 05, 2022
From MarketWatch
From Benzinga
Billionaire Bill Gates Is Betting Against TSLA Stock. Here’s Where He’s Putting His Money Instead.
May 25, 2022
From InvestorPlace
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
WHO urges countries to keep up COVID-19 testing and surveillance as the virus is still a global pandemic
March 30, 2022
From MarketWatch
Are These 2 Rivals Beating Pfizer and Moderna?
March 28, 2022
From Motley Fool
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.